Exhibit 99.1 Doximity Announces Fiscal 2025 First Quarter Financial Results Total revenues of $126.7 million, up 17% year-over-year Net income growth of 46% and adjusted EBITDA growth of 42% year-over-year SAN FRANCISCO, Calif., August 8, 2024 -- Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2025 first quarter ended June 30, 2024. "We were pleased to deliver strong profits and record engagement last quarter, as we beat on both ...

The upcoming earnings release of Doximity will be of great interest to investors. The company's earnings report is expected on August 8, 2024. The company is forecasted to report an EPS of $0.22, showcasing a 15.79% upward movement from the corresponding quarter of the prior year. Alongside, our most recent consensus estimate is anticipating revenue of $119.88 million, indicating a 10.52% upward movement from the same quarter last year. Doximity (DOCS) closed the most recent trading day at $28.66, moving +1 ...

However, in the post-pandemic era, manual workforce shortage within healthcare has become a worldwide problem, weighing heavily on healthcare infrastructure. In April 2023, the National Council of State Boards of Nursing revealed that within United States, 100,000 nurses left the workforce during the pandemic, and by 2027, almost 900,000, or almost one-fifth of 4.5 million total registered nurses, intend to leave the workforce, threatening the national health care system at large if solutions are not enacte ...

Market participants will be closely following the financial results of Doximity in its upcoming release. It is anticipated that the company will report an EPS of $0.22, marking a 15.79% rise compared to the same quarter of the previous year. At the same time, our most recent consensus estimate is projecting a revenue of $119.88 million, reflecting a 10.52% rise from the equivalent quarter last year. The most recent trading session ended with Doximity (DOCS) standing at $27.97, reflecting a +0.5% shift from ...

Doximity operates a digital platform that provides connections between, medical information to, and patient scheduling tools for medical professionals. The Class Period begins on February 9, 2022, when Doximity released its quarterly financial results for the third quarter of fiscal year 2022, after the market closed the night prior. During the accompanying quarterly investor earnings call afterhours on February 8, 2022, Defendant Anna Bryson, the Company's Chief Financial Officer, emphasized that "marketer ...

RADNOR, Pa., June 14, 2024 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities fraud class action lawsuit against Doximity, Inc. (NYSE: DOCS) ("Doximity" or the "Company") on behalf of investors who purchased or acquired Doximity common stock between February 9, 2022, and April 1, 2024, inclusive (the "Class Period"). This action, captioned Kissler v. Doximity, Inc., et al., Case No. 3:24-cv-02281-JST was filed in the United States Di ...

NEW YORK, June 12, 2024 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Doximity, Inc. ("Doximity" or the "Company") (NYSE:DOCS) and reminds investors of the June 17, 2024 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. If you suffered losses exceeding $100,000 investing in Doximity stock or options between February 9, 2022 and April 1, 2024 and would like to ...

NEW YORK, June 12, 2024 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Doximity, Inc. ("Doximity" or the "Company") (NYSE: DOCS) and reminds investors of the June 17, 2024 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. If you suffered losses exceeding $100,000 investing in Doximity stock or options between February 9, 2022 and April 1, 2024 and would like to ...

Important Deadline Reminder: Investors who purchased or otherwise acquired Doximity common stock during the Class Period may, no later than June 17, 2024, move the Court to serve as lead plaintiff for the class. You can also contact attorney Jonathan Naji, Esq. of Kessler Topaz by calling (484) 270-1453 or by email at [email protected]. DEFENDANTS' MISCONDUCT Throughout the Class Period, Defendants continued to tout the sustainability of the Company's business prospects while also downplaying the importance ...

Do you want to discuss your rights? On this news, Doximity's stock price fell $7.49 per share, or nearly 23%, to close at $25.30 per share on August 9, 2023. Since 1993, Bernstein Liebhard LLP has recovered over $3.5 billion for its clients. In addition to representing individual investors, the Firm has been retained by some of the largest public and private pension funds in the country to monitor their assets and pursue litigation on their behalf. As a result of its success litigating hundreds of lawsuits ...